Ementa: Integração e regulação metabólica, proteínas "G" - mensageiros químicos, proteínas quinases, propriedades regulatórias das cascatas metabólicas,
receptor tirosina quinase, fosfoproteínas fosfatases, ativação de JAK e STAT, transportadores de glicose, obesidade, resistência à insulina,
metabolismo de lipoproteínas, diabetes mellitus, produtos finais de glicação avançada, radicais livres e mecanismos antioxidantes. Metodologias
utilizadas na determinação de atividades de enzimas antioxidantes e produtos de lipoperoxidação, papel dos radicais livres e outras espécies
reativas em algumas doenças e no envelhecimento.
Bibliografia: 1- Wang, H-Y, Liu, T., and Malbon, C. C. Structure-function analysis of Frizzleds (REVIEW ARTICLE). Cellular Signalling, v. 18, n. 7, p. 934-941,
2006.
2- Hampoelz, B. and Knoblich, J. A. Heterotrimeric G Proteins: New Tricks for an Old Dog( REVIEW). Cell, v. 119, n. 4, p. 453-456, 2004.
3- Reiter, E. and Lefkowitz, R. J. GRKs and ?-arrestins: roles in receptor silencing, trafficking and signaling (REVIEW ARTICLE). Trends in
Endocrinology & Metabolism, In Press, Corrected Proof, Available online 3 April 2006.
4- Inoue, Y., Yamazaki, Y. and Shimizu, T. How accurately can we discriminate G-protein-coupled receptors as 7-tms TM protein sequences from
other sequences?. Biochemical and Biophysical Research Communications, v. 338, n. 3, p. 1542-1546, 2005.
5-- Kostenis, E. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands (REVIEW).
Pharmacology & Therapeutics, v. 102, n. 3, p. 243-257, 2004.
6- Sakmar, T. P Structure of rhodopsin and the superfamily of seven-helical receptors: the same and not the same (REVIEW). Current Opinion in
Cell Biology, v. 14, n. 2, p. 189-195, 2002.
7- Cherfils, J. and Chabre, M. Activation of G-protein G? subunits by receptors through G?G? and G?G? interactions. Trends in Biochemical
Sciences, V. 28, N. 1, P. 13-17, 2003.
8- Schöneberg, T. Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H. and Sangkuhl, K. Mutant G-protein-coupled receptors as a cause of
human diseases (REVIEW). Pharmacology & Therapeutics, v.104, n. 3, p. 173-206, 2004.
9-.STRYER, L. Bioquímica. 5. ed, Rio de Janeiro: Guanabara Koogan, 2004.
10--Panayotou, G. And Waterfield, M.D. The assembling of signaling complexes by receptor tyrosine kinase. BioEssays v.15, p. 171-177, 1993.
11- Cohen, G.B., Ren, R. And Baltimore, D. Molecular binding domains in signal transduction proteins. Cell, v. 80, p. 237-248, 1995.
12- Heldin, C.H. Dimerization of cell surface receptors in signal transduction. Cell, v. 80, p. 213-223, 1995.
13- Hunter, T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell, v. 80, p. 225-236, 1995.
14- karin, M. And Smeal, T. Control of transcription factors by signal transduction pathways: the beginning of the end. Trends in Biochemical
Sciences, v. 17, p. 418-422, 1992.
15- H. N. Caro, S. Kunjara, T. W. Rademacher, Y. León, D. R. Jones, M. A. Avila and I. Varela-Nieto. Isolation and Partial Characterisation of Insulin-
Mimetic Inositol Phosphoglycans from Human Liver, Biochemical and Molecular Medicine, v. 61, n.. 2, .p.214-228, 1997.
16- Berridge, M.J. Inositol trisphosphate and calcium signaling. Nature v. 361, p. 315-325, 1993.
17-Hubbard, M.J. and Cihen, P. On target with a new mechanism for the regulation of proteins phosphorylation. Trends in Biochemical Sciences v..
18, p. 72-177, 1993.
18- Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "Causal" antioxidant therapy. Diabetes Care, v. 26, n. 5, p.
1589 - 1596, 2003.
19-Lapollaa, A., Traldib, P., and Fedelea, D. Importance of measuring products of non-enzymatic glycation of proteins. Clinical Biochemistry, v.38, p.
103 115, 2005.
20-Ahmed, N. Advanced glycation endproductsrole in pathology of diabetic complications. Diabetes Research and Clinical Practice (67):321,
2005.
21- Richter, T., Müncha, G., Lüth, H-J., Arendt, T. Kientsch-Engel, R., Stahl, P., Fengler, D. and Kuhla, B. Immunochemical crossreactivity of
antibodies specific for advanced glycation endproducts with advanced lipoxidation endproducts. Neurobiology of Aging, v. 26, p.465474, 2005.
22 - Annett Schmitt, A., Schmitt, J. Münch, G. and Gasic-Milencovic, J. Characterization of advanced glycation end products for biochemical studies:
side chain modifications and fluorescence characteristics. Analytical Biochemistry, v. 338, p. 201215, 2005.
23- Sena, S., Karb, Roya, A. and Chakrabortia, A.S. Effect of Nonenzymatic glycation on functional and structural properties of hemoglobin.
Biophysical Chemistry, v. 113, p. 289 298, 2005.
24- Jensen, P. G. and Larson, J. R. Management of Painful Diabetic Neuropathy. Drugs & Aging, v. 18 n. 10, p. 737-749, 2001.
25- WARING, W. S. CONVERY, A. MISHRA,V., SHENKIN, A., WEBB, D. J. and MAXWELL, S. R. J. Uric acid reduces exercise-induced oxidative
stress in healthy adults. Clinical Science v. 105, p. 425430, 2003.
27- Askew, E. W. Work at high altitude and oxidative stress: antioxidant
Nutrients, Toxicology, V. 180, P. 107-119, 2002.
28-Gareth W. Davison g. W., george, Simon K. Jackson, S. J., Young, i. S., Davies, B., Bailey, D. M., Peters, J. R. and Ashton, T. Exercise, free
radicals, and lipid peroxidation in type 1 diabetes mellitus. Free Radical Biology & Medicine, Vol. 33, No. 11, pp. 15431551, 2002.
